Edition:
United Kingdom

Cellect Biotechnology Ltd (APOP.OQ)

APOP.OQ on NASDAQ Stock Exchange Capital Market

7.53USD
11 Dec 2017
Change (% chg)

$-0.27 (-3.46%)
Prev Close
$7.80
Open
$7.65
Day's High
$7.78
Day's Low
$7.51
Volume
7,930
Avg. Vol
12,660
52-wk High
$13.50
52-wk Low
$2.30

Latest Key Developments (Source: Significant Developments)

Cellect Biotechnology reports Q3 ‍loss $0.02/shr​
Wednesday, 22 Nov 2017 

Nov 22 (Reuters) - Cellect Biotechnology Ltd :Cellect Biotechnology Ltd provides corporate update and reports third quarter 2017 financial results.Cellect Biotechnology Ltd - qtrly ‍loss per share $0.02​.  Full Article

Cellect Biotechnology reports Q2 loss per share $0.01
Thursday, 1 Sep 2016 

Cellect Biotechnology Ltd : Cellect Biotechnology Ltd provides corporate update and reports second quarter 2016 financial results .Q2 loss per share $0.01.  Full Article

Cellect Biotechnology sees U.S. IPO of 1.3 mln American depositary shares
Tuesday, 26 Jul 2016 

Cellect Biomed Ltd :Cellect Biotechnology Ltd sees U.S. IPO of 1.3 million American depositary shares - SEC filing.  Full Article

Cellect Biomed files for U.S. IPO of up to $10 mln - SEC Filing
Thursday, 7 Jul 2016 

Cellect Biomed Ltd: Files for U.S. IPO of up to $10.0 million - SEC Filing . Intends to apply to list ADSS on Nasdaq capital market . Proposed IPO price is an estimate solely for purpose of calculating sec registration fee .Rodman Renshaw and Chardan Capital Markets are the underwriters to IPO.  Full Article

BRIEF-Cellect Biotechnology reports Q3 ‍loss $0.02/shr​

* Cellect Biotechnology Ltd provides corporate update and reports third quarter 2017 financial results

No consensus analysis data available.